Back
Speaker illustration

Doctor Sergey Kozhukhov

Strazhensku Cardiology Institute, Kiev (Ukraine)

Member of:

European Society of Cardiology

I am a Head of Clinical Pharmacology Department & Cardio-Oncology Unit in the NSC M.D.Strazhesko Institute of Cardiology, Kiev, Ukraine. My clinical expertise is ACS, acute & chronic HF. My research areas of interest are cardiotoxicity, HF, HT, DM, AF, cardioprotection, new drug & side effects development.

Presentations

Ten-year prognostic impact of acute heart failure in STEMI patients: a prospective cohort study

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Risks for acute coronary syndromes

Access
0
Thumbnail

Prediction of readmission and CV-death in acute decompensated heart failure

Event: Heart Failure 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Heart Failure ePosters - focus on Acute Heart Failure

Access
0
Thumbnail

ACE Insertion/Deletion gene polymorphism aassociations in STEMI Patients

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Coronary Syndromes ePosters

Access
0
Thumbnail

Cardioprotective strategy in ST-elevation acute myocardial infarction patients after reperfusion with percutaneous coronary intervention

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: No Reflow

Session: Acute Coronary Syndromes ePosters

Access
0
Thumbnail

Multicenter randomized clinical trial of the efficacy and safety of intravenous Quercetin in patients with acute decompensated heart failure

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Treatment

Session: Acute Heart Failure

Access
0
Thumbnail

Noninvasive evaluation of single-dose intravenous 5-lipoxygenase inhibitor effect on ventricular repolarization variability in patients with mild-to-moderate chronic heart failure

Event: ESC Congress 2018

Topic: Imaging

Session: Chronic heart failure – Diagnostic methods

Access
0
Thumbnail

Multicenter randomized clinical trial of the efficacy and safety of intravenous quercetin in patients with ST-elevation acute myocardial infarction

Event: ESC Congress 2018

Topic: Reperfusion and Reperfusion Injury

Session: No-reflow prevention and pathophysiology

Access
0
Thumbnail

The clinical profile and outcomes of acute decompensated heart failure in patients with history of hypertension

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Hypertension, Other

Session: Hypertension - Other

Access
0
Thumbnail

Acute heart failure in patients with ST-segment elevation myocardial infarction: prognostic significance of mid-range left ventricular ejection fraction

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Heart Failure – Epidemiology, Prognosis, Outcome

Access
0
Thumbnail

Effects of early statin treatment on acute heart failure and cardiovascular events after st-elevation myocardial infarction

Event: EuroPrevent 2018

Topic: Coronary Artery Disease, Other

Session: Coronary artery disease, acute coronary syndromes, acute cardiac care

Access
0
Thumbnail

ESC 365 is supported by

logo Novo Nordisk